News Articles

We are proud to announce a major milestone for Causaly: successfully passing ISO 27001 certification.

Causaly, the London-based company that allows researchers and specialists to intuitively map and navigate the intricate landscape of biomedical research, has raised $17 million from investors to grow its team and expand into new markets.

At Causaly we’re excited to announce a new partnership with University College London (UCL) to help accelerate research into the pandemic

London, November 19 – Causaly, the AI company that is teaching computers to read, understand and interpret all biomedical knowledge ever published, is pleased to announce its series A funding round, which saw new and existing investors commit $4.8m into the company. Pentech Ventures led the round together with EBRD Venture Capital, with participation from existing investors Marathon Venture Capital as well as existing angel investors.